Filing Details
- Accession Number:
- 0001077183-19-000059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-06 17:33:00
- Reporting Period:
- 2019-05-02
- Accepted Time:
- 2019-05-06 17:33:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640500 | Jennifer Balliet | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | Vp And Chief Culture Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-02 | 16,667 | $7.15 | 39,529 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-05-02 | 13,333 | $7.52 | 52,862 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-05-03 | 16,667 | $22.74 | 36,195 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-05-03 | 13,333 | $22.74 | 22,862 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-02 | 16,667 | $7.15 | 16,667 | $7.15 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-02 | 13,333 | $7.52 | 13,333 | $7.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-04-20 | 2021-04-20 | No | 4 | M | Direct |
26,667 | 2018-04-28 | 2022-04-28 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $19.60 | 2020-03-01 | 2024-03-01 | 17,496 | 17,496 | Direct |
Common Stock | Stock Option (Right to Buy) | $8.03 | 2019-02-26 | 2023-02-26 | 48,500 | 48,500 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2024-03-01 | 17,496 | 17,496 | Direct |
2023-02-26 | 48,500 | 48,500 | Direct |
Footnotes
- On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- On March 1, 2019, Ms. Balliet was granted 17,496 stock options which vested ratably over the first four anniversary dates of the grant date.
- On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vested ratably over the first three anniversary dates of the grant date.
- On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date.